il 22 (MedChemExpress)
Structured Review

Il 22, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 22/product/MedChemExpress
Average 93 stars, based on 13 article reviews
Images
1) Product Images from "IL-22 attenuates MAFLD progression by modulating oxidative stress and ferroptosis"
Article Title: IL-22 attenuates MAFLD progression by modulating oxidative stress and ferroptosis
Journal: Scientific Reports
doi: 10.1038/s41598-025-28718-8
Figure Legend Snippet: Effect of IL-22 on liver appearance, body weight, and liver weight in CDAHFD-fed mice. (A) The scheme of the experimental study design. (B) Liver image. (C) Changes in mice body weight over the feeding period. (D) Measurement of liver weight. (E) The liver-to-body weight ratio. ( n = 8 for all). # p < 0.05, ## p < 0.005, and ### p < 0.001 vs. the Control group. * p < 0.05, ** p < 0.005, and *** p < 0.001 vs. the CDAHFD group.Abbreviation: CDAHFD, choline-deficient, L-amino acid-defined, high-fat diet.
Techniques Used: Control
Figure Legend Snippet: IL-22 reduced hepatic lipid accumulation in the CDAHFD mice. (A) Oil Red O staining of liver tissues. (Scale bar: 100 μm; original magnification: × 200) (B) HE staining of liver tissues. (Scale bar: 100 μm; original magnification: × 200) ( C ) TG levels; ( D ) TC levels; (E) LDL-C levels; (F) HDL-C levels; (G) Serum ALT content; (H) Serum AST content. ( n = 8 for panels C to H). (I) Measurement of Oil Red O-stained area; (J) Evaluation of MAFLD activity score. ( n = 3 for panels I and J). # p < 0.05, ## p < 0.005, and ### p < 0.001 vs. the Control group. * p < 0.05, ** p < 0.005, and *** p < 0.001 vs. the CDAHFD group. Abbreviation: ALT, alanine aminotransferase; AST, aspartate aminotransferase; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MAFLD, Metabolic-associated fatty liver disease.
Techniques Used: Staining, Activity Assay, Control
Figure Legend Snippet: Mitigation of hepatic damage and fibrosis by IL-22 treatment in CDAHFD-induced mice. (A) MASSON staining of liver sections. (Scale bar: 100 μm; original magnification: × 200) (B) IHC staining of liver sections for α-SMA. (Scale bar: 100 μm; original magnification: × 100) (C) Area of liver fibrous expression; (D) Areas of α-SMA positive expression. ( E) α-SMA protein expression was determined by western blotting. (F) Relative mRNA level of α-SMA; (G) Relative protein expression of α-SMA. ( n = 3 for panels C, D, F and G). (H) The level of hyp; ( I ) Serum IL-6 level; ( J ) Serum IL-1β level; ( K ) Serum TNF-α level. ( n = 8 for panels H to K). # p < 0.05, ## p < 0.005, and ### p < 0.001 vs. the Control group. * p < 0.05, ** p < 0.005, and *** p < 0.001 vs. the CDAHFD group. Abbreviation: IHC, Immunohistochemistry; α-SMA, alpha Smooth Muscle Actin; hyp, hydroxyproline.
Techniques Used: Staining, Immunohistochemistry, Expressing, Western Blot, Control
Figure Legend Snippet: IL-22 intervention mitigated oxidative stress and ferroptosis in CDAHFD-fed mice liver. ( A ) Representative pictures of DHE staining. (Scale bar: 100 μm; original magnification: × 200). ( B ) Measurement of hepatic SOD content. ( C ) Measurement of hepatic MDA content. ( D ) Measurement of hepatic GSH content. ( E ) Measurement of hepatic Fe2 + content. ( n = 8 for panels B to E). ( F ) Mitochondria by transmission electron microscope. (The red arrows indicate the ruptured outer membrane. Scale bar = 1 μm.) # p < 0.05, ## p < 0.005, and ### p < 0.001 vs. the Control group. * p < 0.05, ** p < 0.005, and *** p < 0.001 vs. the CDAHFD group. Abbreviation: DHE, Dihydroethidium; SOD, superoxide dismutase; MDA, malondialdehyde; GSH, glutathion.
Techniques Used: Staining, Transmission Assay, Microscopy, Membrane, Control
Figure Legend Snippet: IL-22 activated the Nrf2/Gpx4/Slc7a11 signal pathway to improve oxidative stress and ferroptosis. (A-E) mRNA expression of Nrf2, Keap1, Hmox1, Gpx4, and Slc7a11 in liver tissues. ( n = 3). (F) Nrf2, Keap1, Hmox1, Gpx4, and Slc7a11 protein expressions were detected by western blotting. ( G ) Representative pictures of liver Nrf2 immunofluorescence staining. (Scale bar: 50 μm; original magnification: × 400). # p < 0.05, ## p < 0.005, and ### p < 0.001 vs. the Control group. * p < 0.05, ** p < 0.005, and *** p < 0.001 vs. the CDAHFD group. Abbreviation: Keap1, Kelch-like ECH-associated protein 1; Nrf2, Nuclear factor erythroid 2-related factor 2; Hmox1, Heme Oxygenase-1; Gpx4, glutathione peroxidase 4; Slc7a11, Solute Carrier Family 7 Member 11.
Techniques Used: Expressing, Western Blot, Immunofluorescence, Staining, Control
Figure Legend Snippet: IL-22 intervention mitigated lipid deposition in FFA-induced AML-12 cells. ( A ) Oil Red O staining (Scale bar: 50 μm; original magnification: × 400). ( B ) TG level. ( n = 3) ( C ) Quantification of Oil Red O-stained area. ( n = 3). # p < 0.05, ## p < 0.005, and ### p < 0.001 vs. the Control group. * p < 0.05, ** p < 0.005, and *** p < 0.001 vs. the Model group.
Techniques Used: Staining, Control
Figure Legend Snippet: IL-22 activated the Nrf2/Gpx4/Slc7a11 signal pathway in AML-12 cells. ( A ) Measurements of SOD content. ( B ) Measurements of MDA content. ( C ) Measurements of GSH content. (D) Keap1, Nrf2, and Hmox1 protein expressions were detected by western blotting. ( E ) mRNA expression of Keap1, Nrf2, and Hmox1. (F) Gpx4 and Slc7a11 protein expressions were detected by western blotting. (G) mRNA expression of Gpx4 and Slc7a1. ( n = 3 for panels A, B, C, E, G). # p < 0.05, ## p < 0.005, and ### p < 0.001 vs. the Control group. * p < 0.05, ** p < 0.005, and *** p < 0.001 vs. the Model group. Abbreviation: SOD, superoxide dismutase; MDA, malondialdehyde; GSH, glutathione; Keap1, Kelch-like ECH-associated protein 1; Nrf2, Nuclear factor erythroid 2-related factor 2; Hmox1, Heme Oxygenase-1 Gpx4, glutathione peroxidase 4; Slc7a11, Solute Carrier Family 7 Member 11.
Techniques Used: Western Blot, Expressing, Control
Figure Legend Snippet: ML385 weakened the antioxidant effects of IL-22 in AML-12 cells. ( A ) Oil Red O staining (Scale bar: 50 μm; original magnification: × 400). ( B ) Quantification of Oil Red O-stained area. ( C ) TG level. (D) Measurements of SOD content. ( E ) Measurements of MDA content. ( F ) Measurements of GSH content. (G) mRNA expression of Nrf2, Hmox1, Gpx4, Slc7a11. ( n = 3 for panels B to G) # p < 0.05, ## p < 0.005, and ### p < 0.001 vs. the Control group. * p < 0.05, ** p < 0.005, and *** p < 0.001 vs. the Model group. & p < 0.05, && p < 0.005, and &&& p < 0.001 vs. the IL-22-H group. Abbreviation: TG, triglyceride; SOD, superoxide dismutase; MDA, malondialdehyde; GSH, glutathione; Nrf2, Nuclear factor erythroid 2-related factor 2; Hmox1, Heme Oxygenase-1 Gpx4, glutathione peroxidase 4; Slc7a11, Solute Carrier Family 7 Member 11.
Techniques Used: Staining, Expressing, Control
Figure Legend Snippet: A schematic model illustrating that IL-22 alleviates MAFLD by activating the Nrf2/Gpx4/Slc7a11 axis to suppress oxidative stress and ferroptosis. Arrows denote activating effects; blunted lines denote inhibitory effects.
Techniques Used:
